Influence of Foot Types on Collegiate Athletes
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05992129 |
Recruitment Status :
Completed
First Posted : August 15, 2023
Last Update Posted : August 15, 2023
|
Sponsor:
Universidad del Magdalena
Information provided by (Responsible Party):
Orlando Santiago Moreno Barriga, Universidad del Magdalena
Tracking Information | |||||||
---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | July 14, 2023 | ||||||
First Posted Date ICMJE | August 15, 2023 | ||||||
Last Update Posted Date | August 15, 2023 | ||||||
Actual Study Start Date ICMJE | August 1, 2022 | ||||||
Actual Primary Completion Date | December 21, 2022 (Final data collection date for primary outcome measure) | ||||||
Current Primary Outcome Measures ICMJE |
|
||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||
Change History | No Changes Posted | ||||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||
Descriptive Information | |||||||
Brief Title ICMJE | Influence of Foot Types on Collegiate Athletes | ||||||
Official Title ICMJE | Structural Foot Types and Their Influence on Core Strength and Athletic Performance in Collegiate Athletes | ||||||
Brief Summary | The purpose of the study is to assess whether high or low arch foot types influence the overall performance of the athlete. | ||||||
Detailed Description | After meeting the eligibility criteria for the study, university athletes have their general athletic condition variables evaluated in the laboratory and in the field. Subsequently, athletes with high and low arches perform 12-week foot muscle strengthening exercises to re-evaluate the variables in both athletes with high and low arch types who performed the strengthening exercises, as well as those with neutral arch who did not perform the exercises. | ||||||
Study Type ICMJE | Interventional | ||||||
Study Phase ICMJE | Not Applicable | ||||||
Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Parallel Assignment Intervention Model Description: After initial measurements of dependent variables (electromyographic activity amplitude of core muscles, static stability, dynamic stability, ergospirometry, countermovement jump, and 40m sprint test), athletes are divided into two groups: 1) Case group, which is further classified into (a) athletes with high arched feet and (b) athletes with flat feet, and 2) Control group, consisting of athletes with neutral feet. The case group performs intrinsic and extrinsic foot muscle strengthening exercises for 12 weeks, while the control group does not engage in these exercises. Following intervention, both case and control groups are re-evaluated in dependent variables to conduct pre-post intervention variable comparisons. Masking: None (Open Label)Primary Purpose: Supportive Care |
||||||
Condition ICMJE | Healthy | ||||||
Intervention ICMJE | Other: foot exercise
These are foot and ankle muscle strengthening exercises described and evaluated by the literature
|
||||||
Study Arms ICMJE |
|
||||||
Publications * |
|
||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||
Recruitment Information | |||||||
Recruitment Status ICMJE | Completed | ||||||
Actual Enrollment ICMJE |
97 | ||||||
Original Actual Enrollment ICMJE | Same as current | ||||||
Actual Study Completion Date ICMJE | May 19, 2023 | ||||||
Actual Primary Completion Date | December 21, 2022 (Final data collection date for primary outcome measure) | ||||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||
Sex/Gender ICMJE |
|
||||||
Ages ICMJE | 18 Years to 26 Years (Adult) | ||||||
Accepts Healthy Volunteers ICMJE | Yes | ||||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||
Listed Location Countries ICMJE | Colombia | ||||||
Removed Location Countries | |||||||
Administrative Information | |||||||
NCT Number ICMJE | NCT05992129 | ||||||
Other Study ID Numbers ICMJE | CTUM212170 | ||||||
Has Data Monitoring Committee | No | ||||||
U.S. FDA-regulated Product |
|
||||||
IPD Sharing Statement ICMJE | Not Provided | ||||||
Current Responsible Party | Orlando Santiago Moreno Barriga, Universidad del Magdalena | ||||||
Original Responsible Party | Same as current | ||||||
Current Study Sponsor ICMJE | Universidad del Magdalena | ||||||
Original Study Sponsor ICMJE | Same as current | ||||||
Collaborators ICMJE | Not Provided | ||||||
Investigators ICMJE |
|
||||||
PRS Account | Universidad del Magdalena | ||||||
Verification Date | August 2023 | ||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |